ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,852 | +5.6% | 4,200 | -47.5% | 0.00% | – |
| Q1 2022 | $231,000 | -21.7% | 8,000 | +27.0% | 0.00% | – |
| Q4 2021 | $295,000 | +2.1% | 6,300 | -37.6% | 0.00% | – |
| Q4 2020 | $289,000 | -55.1% | 10,100 | -11.4% | 0.00% | -100.0% |
| Q3 2018 | $644,000 | -28.2% | 11,400 | -26.0% | 0.00% | 0.0% |
| Q2 2018 | $897,000 | 0.0% | 15,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $897,000 | +7.3% | 15,400 | +18.7% | 0.00% | -33.3% |
| Q4 2017 | $836,000 | -38.6% | 12,978 | -55.0% | 0.00% | -50.0% |
| Q2 2017 | $1,362,000 | -37.8% | 28,854 | -34.5% | 0.01% | -50.0% |
| Q1 2017 | $2,188,000 | +534.2% | 44,065 | +673.9% | 0.01% | +500.0% |
| Q4 2016 | $345,000 | -87.3% | 5,694 | -88.2% | 0.00% | -86.7% |
| Q2 2016 | $2,719,000 | – | 48,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |